Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-Sensitive Prostate Cancer”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06463457
What this trial is testing

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Who this might be right for
Prostate CancerAdvanced Prostate CancerHormone Sensitive Prostate Cancer
Atish Choudhury, MD 33
Not applicableLooking for participantsNCT04612907
What this trial is testing

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate CancerRadiotherapy Side EffectMetastatic Cancer
Umeå University 420
Not applicableStudy completedNCT06072196
What this trial is testing

Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Who this might be right for
Prostatic Neoplasms
Pfizer 3,017
Large-scale testing (Phase 3)Study completedNCT04934722
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Merck Sharp & Dohme LLC 186
Not applicableStudy completedNCT06498921
What this trial is testing

An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 106
Large-scale testing (Phase 3)Ended earlyNCT04409288
What this trial is testing

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 74
Not applicableUnknownNCT04220398
What this trial is testing

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate CancerChemotherapy EffectHormone Sensitive Prostate Cancer+1 more
RenJi Hospital 475
Early research (Phase 1)Study completedNCT00148928
What this trial is testing

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 25
Not applicableUnknownNCT02723526
What this trial is testing

Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Fudan University 100
Early research (Phase 1)Ended earlyNCT05733351
What this trial is testing

Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Emory University 4
Testing effectiveness (Phase 2)Looking for participantsNCT07005154
What this trial is testing

Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 218
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Not applicableActive Not RecruitingNCT06019676
What this trial is testing

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Royal Marsden NHS Foundation Trust 170
Testing effectiveness (Phase 2)Study completedNCT02058706
What this trial is testing

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Barbara Ann Karmanos Cancer Institute 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04925063
What this trial is testing

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 266
Testing effectiveness (Phase 2)Study completedNCT02278185
What this trial is testing

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage III Prostate Cancer+1 more
University of Colorado, Denver 19
Not applicableStudy completedNCT06452212
What this trial is testing

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Astellas Pharma Korea, Inc. 23
Large-scale testing (Phase 3)Looking for participantsNCT06496581
What this trial is testing

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Who this might be right for
Prostate Cancer Metastatic
UNICANCER 500
Not applicableUnknownNCT05530395
What this trial is testing

BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

Who this might be right for
Prostate Cancer Metastatic
Ignacio Puche Sanz 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Load More Results